- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
TSON Market Currents
more »
-
March 9 TranS1 (TSON -5.3%) dips after posting disappointing Q4 results. Revenue fell 32% Y/Y despite a sharp improvement in margins, as the company continues to post declining revenue and quarterly losses. Additionally, the medical device maker forecast Q1 revenue to be lower, now expecting to earn between $3.5M - $3.9M, below the Street consensus forecast of $4M.
Comment![Earnings, Healthcare, On the Move]
TSON in Focus
more »
TSON Related Articles
more »
TSON News
more »
Currently, there are no news on TSON.
TSON Press Releases and Filings
more »
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (May 2, 2012)
-
GlobeNewswire (Apr 25, 2012)
-
GlobeNewswire (Apr 5, 2012)
-
GlobeNewswire (Jan 26, 2012)
TSON Latest Transcript
more »
-
Tue, May 4, 2010
TSON Cramer
more »
Currently, there are no Cramer articles on TSON.
TSON Instablog posts
more »
TSON vs. ETF Alternatives
Company Description
Currently, there's no company description for TSON.